Stifel Financial’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $451K | Buy |
+4,322
| New | +$451K | ﹤0.01% | 2836 |
|
|
2021
Q3 | – | Sell |
-406,935
| Closed | -$27.5M | – | 3334 |
|
|
2021
Q2 | $27.5M | Buy |
406,935
+136
| +0% | +$9.18K | 0.04% | 363 |
|
|
2021
Q1 | $23M | Buy |
406,799
+769
| +0.2% | +$43.5K | 0.04% | 391 |
|
|
2020
Q4 | $33.1M | Sell |
406,030
-538
| -0.1% | -$43.8K | 0.06% | 285 |
|
|
2020
Q3 | $29M | Sell |
406,568
-30
| -0% | -$2.14K | 0.06% | 280 |
|
|
2020
Q2 | $33.5M | Buy |
406,598
+2,453
| +0.6% | +$202K | 0.08% | 238 |
|
|
2020
Q1 | $23.8M | Hold |
404,145
| – | – | 0.07% | 256 |
|
|
2019
Q4 | $41.8M | Hold |
404,145
| – | – | 0.09% | 225 |
|
|
2019
Q3 | $8.18M | Sell |
404,145
-374
| -0.1% | -$7.57K | 0.02% | 637 |
|
|
2019
Q2 | $10.4M | Buy |
404,519
+374
| +0.1% | +$9.63K | 0.03% | 558 |
|
|
2019
Q1 | $5.75M | Hold |
404,145
| – | – | 0.02% | 754 |
|
|
2018
Q4 | $1.14M | Hold |
404,145
| – | – | ﹤0.01% | 1449 |
|
|
2018
Q3 | $1.39M | Hold |
404,145
| – | – | ﹤0.01% | 1466 |
|
|
2018
Q2 | $1.29M | Hold |
404,145
| – | – | ﹤0.01% | 1456 |
|
|
2018
Q1 | $990K | Sell |
404,145
-11,134
| -3% | -$27.3K | ﹤0.01% | 1568 |
|
|
2017
Q4 | $2.33M | Hold |
415,279
| – | – | 0.01% | 1082 |
|
|
2017
Q3 | $2.31M | Hold |
415,279
| – | – | 0.01% | 1046 |
|
|
2017
Q2 | $2.28M | Hold |
415,279
| – | – | 0.01% | 1040 |
|
|
2017
Q1 | $1.62M | Hold |
415,279
| – | – | 0.01% | 1178 |
|
|
2016
Q4 | $2.8M | Hold |
415,279
| – | – | 0.01% | 893 |
|
|
2016
Q3 | $3.27M | Buy |
+415,279
| New | +$3.27M | 0.01% | 796 |
|